These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4970194

  • 1. [Biochemical and immunological reactivity of the histoid macrophage in tuberculosis. IV. The effect of hyperimmune serum on the interaction between the tubercular bacillus and the histoid macrophage of the noraml animal and BCG vaccinated animal].
    Păunescu E.
    Microbiol Parazitol Epidemiol (Bucur); 1968; 13(1):39-45. PubMed ID: 4970194
    [No Abstract] [Full Text] [Related]

  • 2. The macrophage in tuberculosis.
    Berthrong M.
    Bibl Tuberc; 1970; 26():1-27. PubMed ID: 4984113
    [No Abstract] [Full Text] [Related]

  • 3. IN VITRO STUDIES ON THE INTERACTIONS BETWEEN MACROPHAGES OF RABBITS AND TUBERCLE BACILLI. II. CELLULAR AND HUMORAL ASPECTS OF ACQUIRED RESISTANCE.
    HSU HS.
    Am Rev Respir Dis; 1965 Apr; 91():499-509. PubMed ID: 14263929
    [No Abstract] [Full Text] [Related]

  • 4. The capacity of macrophage components to inhibit anti-macrophage serum activity.
    Schroit AJ, Geiger B, Gallily R.
    Eur J Immunol; 1973 Jun; 3(6):354-9. PubMed ID: 4586169
    [No Abstract] [Full Text] [Related]

  • 5. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [Abstract] [Full Text] [Related]

  • 6. Cultural, phagocytic, and bactericidal characteristics of peritoneal macrophages.
    Hirt WE, Bonventre PF.
    J Reticuloendothel Soc; 1973 Jan; 13(1):27-46. PubMed ID: 4633541
    [No Abstract] [Full Text] [Related]

  • 7. Differences in the cytotoxic effect of rabbit anti-rat macrophage sera on rat alveolar and peritoneal macrophages.
    Boltz-Nitulescu G, Förster O.
    Immunobiology; 1980 Jan; 156(4-5):331-41. PubMed ID: 7372347
    [No Abstract] [Full Text] [Related]

  • 8. [Preparation of antimacrophage serum and study of its "in vitro" and "in vivo" activity (author's transl)].
    Forestier F, Cotte J, Quéro AM, German A.
    Ann Pharm Fr; 1979 Jan; 37(7-8):249-56. PubMed ID: 539732
    [No Abstract] [Full Text] [Related]

  • 9. [A vital luminescent-serologic study of intracellular processes during phagocytosis of brucellae by macrophages].
    Korn MIa, Shuvalov LP.
    Biull Eksp Biol Med; 1975 Feb; 79(2):70-4. PubMed ID: 805604
    [No Abstract] [Full Text] [Related]

  • 10. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ, Kursar M, Kaufmann SH.
    J Infect Dis; 2004 Aug 01; 190(3):588-97. PubMed ID: 15243936
    [Abstract] [Full Text] [Related]

  • 11. [Influence of immune sera on the phagocytosis of Mycobacterium tuberculosis by macrophages].
    Dykhno MM, Kheĭfets LB, Pushkar NV.
    Probl Tuberk; 1972 Aug 01; 50(8):75-8. PubMed ID: 4626692
    [No Abstract] [Full Text] [Related]

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 13. Phagocytosis and intracellular fate of Mycobacterium tuberculosis: in vitro studies with guinea pig peritoneal and alveolar mononuclear phagocytes.
    Maxwell KW, Marcus S.
    J Immunol; 1968 Jul 01; 101(1):176-82. PubMed ID: 4969528
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of antimacrophage serum on immunity to tuberculosis].
    Averbakh MM, Litvinov VI, Moroz AM.
    Probl Tuberk; 1974 Jul 01; 52(5):70-4. PubMed ID: 4847883
    [No Abstract] [Full Text] [Related]

  • 15. [Phagocytosis of differently treated Candida cells by chicken bone marrow- and peritoneal macrophages (author's transl)].
    Rossi G, Turba F.
    Mykosen; 1981 Nov 01; 24(11):684-94. PubMed ID: 7033777
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J, Doherty TM.
    APMIS; 2009 May 01; 117(5-6):440-57. PubMed ID: 19400867
    [Abstract] [Full Text] [Related]

  • 17. [Immunobiology of tubercle bacilli antigens].
    Göing H.
    Z Immunitatsforsch Allerg Klin Immunol; 1967 May 01; 132(5):443-59. PubMed ID: 4231355
    [No Abstract] [Full Text] [Related]

  • 18. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC.
    Vaccine; 2009 Jul 16; 27(33):4412-23. PubMed ID: 19500523
    [Abstract] [Full Text] [Related]

  • 19. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 20. [The immunogenic characteristics of the recombinant 38,000 antigen from Mycobacterium tuberculosis].
    He X, Zhuang Y, Zhang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug 12; 23(8):485-8. PubMed ID: 11778264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.